These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16814670)

  • 41. Mechanisms of ischemic preconditioning and clinical implications for multiorgan ischemic-reperfusion injury.
    Lee HT
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):78-91. PubMed ID: 10069291
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?
    Yogaratnam JZ; Laden G; Guvendik L; Cowen M; Cale A; Griffin S
    J Surg Res; 2008 Sep; 149(1):155-64. PubMed ID: 17996900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oestrogen plays a permissive role in cardioprotection.
    Cohen MV; Downey JM
    Cardiovasc Res; 2008 Aug; 79(3):353-4. PubMed ID: 18539628
    [No Abstract]   [Full Text] [Related]  

  • 44. The unorthodox and orthodox: the therapeutic role of acadesine after traumatic injury and sepsis.
    Unkle DW
    Crit Care Med; 1999 Mar; 27(3):468-9. PubMed ID: 10199518
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
    Garcia-Dorado D; Ruiz-Meana M; Piper HM
    Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perioperative infarction: pathogenesis and prevention.
    Symes JF; Sniderman AD; Poirier NL; Mickelborough L; Dobell AR
    Surg Forum; 1978; 29():282-3. PubMed ID: 401164
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
    Balakumar P; Rohilla A; Singh G; Singh K; Singh M
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine: trigger and mediator of cardioprotection.
    Cohen MV; Downey JM
    Basic Res Cardiol; 2008 May; 103(3):203-15. PubMed ID: 17999026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cardiological options for acute protection of the reperfused myocardium].
    Breuckmann F; Heusch G; Erbel R; Philipp S
    Dtsch Med Wochenschr; 2008 Mar; 133(12):591-4. PubMed ID: 18335391
    [No Abstract]   [Full Text] [Related]  

  • 53. [Ischemic postconditioning and its application in organ transplantation].
    Niu Y; Ye QF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):548-52. PubMed ID: 18600006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IB-MECA and cardioprotection.
    Xu Z; Jang Y; Mueller RA; Norfleet EA
    Cardiovasc Drug Rev; 2006; 24(3-4):227-38. PubMed ID: 17214599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Casual bystander or active participant? New clues about adiponectin and traumatic injury.
    White M; Laffey JG; Kevin LG
    Crit Care Med; 2011 Aug; 39(8):2007-8. PubMed ID: 21768810
    [No Abstract]   [Full Text] [Related]  

  • 56. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
    Stumpner J; Redel A; Kellermann A; Lotz CA; Blomeyer CA; Smul TM; Kehl F; Roewer N; Lange M
    Anesthesiology; 2009 Dec; 111(6):1257-64. PubMed ID: 19934869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From coronary steal to myocardial, renal, and cerebral protection: more questions than answers in anaesthetic preconditioning?
    Kunst G
    Br J Anaesth; 2014 Jun; 112(6):958-60. PubMed ID: 24574506
    [No Abstract]   [Full Text] [Related]  

  • 59. [Protective effect of heat-shock protein 27 on myocardium with isoflurane preconditioning in myocardial ischemia/reperfusion injury of myocardium in rabbit].
    Ran K; Zhu R; Lu XH; Zou DQ; Li H; Chang YT
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):683-6. PubMed ID: 17996138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of acadesine on myocardial ischaemia in patients with coronary artery disease.
    de Jonge R; Macleod DC; Suryapranata H; van Es GA; Friedman J; Serruys PW; de Jong JW
    Eur J Pharmacol; 1997 Oct; 337(1):41-4. PubMed ID: 9389379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.